Cue Biopharma, Inc. (CUE) Tops Q1 EPS by 4c

Cue Biopharma, Inc. (NASDAQ: CUE) reported Q1 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $733.33 thousand.

For earnings history and earnings-related data on Cue Biopharma, Inc. (CUE) click here.

You May Also Be Interested In

• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c